rs202213517

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2

The NM_012144.4(DNAI1):​c.862C>T​(p.Arg288Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000915 in 1,614,022 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R288R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00095 ( 20 hom. )

Consequence

DNAI1
NM_012144.4 missense

Scores

10
6
1

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:5

Conservation

PhyloP100: 6.86

Publications

3 publications found
Variant links:
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
DNAI1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 8: AlphaMissense, BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.0115557015).
BP6
Variant 9-34497160-C-T is Benign according to our data. Variant chr9-34497160-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 220955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000598 (91/152250) while in subpopulation SAS AF = 0.0174 (84/4820). AF 95% confidence interval is 0.0144. There are 0 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 20 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012144.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAI1
NM_012144.4
MANE Select
c.862C>Tp.Arg288Trp
missense
Exon 10 of 20NP_036276.1A0A140VJI0
DNAI1
NM_001281428.2
c.874C>Tp.Arg292Trp
missense
Exon 10 of 20NP_001268357.1A0A087WWV9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAI1
ENST00000242317.9
TSL:1 MANE Select
c.862C>Tp.Arg288Trp
missense
Exon 10 of 20ENSP00000242317.4Q9UI46-1
DNAI1
ENST00000878474.1
c.955C>Tp.Arg319Trp
missense
Exon 11 of 21ENSP00000548533.1
DNAI1
ENST00000614641.4
TSL:5
c.874C>Tp.Arg292Trp
missense
Exon 10 of 20ENSP00000480538.1A0A087WWV9

Frequencies

GnomAD3 genomes
AF:
0.000598
AC:
91
AN:
152132
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0174
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00177
AC:
444
AN:
251456
AF XY:
0.00245
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000948
AC:
1386
AN:
1461772
Hom.:
20
Cov.:
31
AF XY:
0.00137
AC XY:
999
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0142
AC:
1224
AN:
86256
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53414
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000693
AC:
77
AN:
1111908
Other (OTH)
AF:
0.00131
AC:
79
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
104
208
312
416
520
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000598
AC:
91
AN:
152250
Hom.:
0
Cov.:
32
AF XY:
0.000927
AC XY:
69
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41556
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0174
AC:
84
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68018
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000743
Hom.:
1
Bravo
AF:
0.000106
ExAC
AF:
0.00196
AC:
238
Asia WGS
AF:
0.00664
AC:
23
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Primary ciliary dyskinesia (3)
1
-
1
Kartagener syndrome (2)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.65
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.40
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.96
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.012
T
MetaSVM
Pathogenic
0.82
D
MutationAssessor
Pathogenic
3.5
H
PhyloP100
6.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-7.2
D
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.93
MutPred
0.55
Loss of disorder (P = 0.0135)
MVP
0.98
MPC
0.56
ClinPred
0.23
T
GERP RS
6.0
Varity_R
0.79
gMVP
0.84
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202213517; hg19: chr9-34497158; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.